Julie Mann - Neogen VP Officer

NEOG Stock  USD 14.98  0.40  2.74%   

Insider

Julie Mann is VP Officer of Neogen
Age 59
Address 620 Lesher Place, Lansing, MI, United States, 48912-1595
Phone517 372 9200
Webhttps://www.neogen.com

Neogen Management Efficiency

The Neogen's current Return On Tangible Assets is estimated to increase to -0.0099. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Neogen's Other Current Assets are most likely to increase significantly in the upcoming years. The Neogen's current Total Current Assets is estimated to increase to about 618.7 M, while Other Assets are projected to decrease to 0.95. Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.
Neogen currently holds 906.24 M in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Neogen has a current ratio of 8.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Neogen's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Ryan BondAclarion
52
Shibu KizhakevilayilHealthcare Triangle
52
Suresh VenkatachariHealthcare Triangle
57
Ken PersenHeartbeam
N/A
Jon BatesNutex Health
54
Lakshmanan KannappanHealthcare Triangle
57
Wei ChenEUDA Health Holdings
39
Lawrence FACSNutex Health
75
BSN JDNutex Health
N/A
MD MBANutex Health
51
John LorbieckiAclarion
61
Jon HuntHeartbeam
68
Elizabeth HallNutex Health
N/A
Denise PufalNutex Health
N/A
FACC MDHeartbeam
65
Michael GillHealthcare Triangle
46
Thyagarajan RamachandranHealthcare Triangle
48
Sudish MogliHealthcare Triangle
55
Branislav VajdicHeartbeam
69
LaChoenda RosalesNutex Health
N/A
Steven SobakEUDA Health Holdings
78
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people. Neogen (NEOG) is traded on NASDAQ Exchange in USA. It is located in 620 Lesher Place, Lansing, MI, United States, 48912-1595 and employs 2,917 people. Neogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Neogen Leadership Team

Elected by the shareholders, the Neogen's board of directors comprises two types of representatives: Neogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neogen. The board's role is to monitor Neogen's management team and ensure that shareholders' interests are well served. Neogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Quinlan, CFO, Principal Accounting Officer, VP and Secretary
Bill Waelke, Head Relations
John Moylan, Corporate VP
Julie Mann, VP Officer
Amy Rocklin, Chief Secretary
David Naemura, Chief Officer
Sarah Demey, Administrative Manager
Robert Donofrio, Vice President - Food Safety Research and Development
Douglas Jones, COO VP
John Adent, CEO President

Neogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.86)
Earnings Share
(0.11)
Revenue Per Share
4.212
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0085
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.